Market Closed -
Swiss Exchange
11:31:30 2024-04-26 EDT
|
5-day change
|
1st Jan Change
|
3.36
CHF
|
+5.00%
|
|
-0.30%
|
-2.33%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
377.3
|
604.8
|
575.4
|
200.5
|
113
|
110.4
|
-
|
-
|
Enterprise Value (EV)
1 |
283.5
|
431.1
|
442.6
|
-48.67
|
113
|
110.4
|
110.4
|
110.4
|
P/E ratio
|
-10.2
x
|
-8.27
x
|
-8.65
x
|
1.74
x
|
-1.82
x
|
-1.98
x
|
-1.81
x
|
-1.53
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
18.5
x
|
65
x
|
59
x
|
1.06
x
|
16.1
x
|
7.97
x
|
5.92
x
|
6.21
x
|
EV / Revenue
|
18.5
x
|
65
x
|
59
x
|
1.06
x
|
16.1
x
|
7.97
x
|
5.92
x
|
6.21
x
|
EV / EBITDA
|
-11
x
|
-10.9
x
|
-9.46
x
|
1.68
x
|
-1.93
x
|
-2.05
x
|
-2.29
x
|
-1.66
x
|
EV / FCF
|
-170
x
|
-19.9
x
|
-6.26
x
|
1.71
x
|
-1.9
x
|
-1.64
x
|
-1.56
x
|
-1.3
x
|
FCF Yield
|
-0.59%
|
-5.03%
|
-16%
|
58.6%
|
-52.7%
|
-60.8%
|
-64%
|
-77%
|
Price to Book
|
6.99
x
|
5.64
x
|
5.34
x
|
0.85
x
|
-
|
0.98
x
|
1.54
x
|
6.24
x
|
Nbr of stocks (in thousands)
|
21,537
|
29,146
|
32,292
|
32,545
|
32,854
|
32,869
|
-
|
-
|
Reference price
2 |
17.52
|
20.75
|
17.82
|
6.160
|
3.440
|
3.360
|
3.360
|
3.360
|
Announcement Date
|
20-02-06
|
21-02-05
|
22-03-15
|
23-03-09
|
24-03-14
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
20.4
|
9.3
|
9.754
|
189.6
|
7
|
13.86
|
18.66
|
17.79
|
EBITDA
1 |
-34.19
|
-55.44
|
-60.85
|
119
|
-58.69
|
-53.98
|
-48.25
|
-66.56
|
EBIT
1 |
-37.2
|
-58.3
|
-63.42
|
116.6
|
-61.1
|
-63.2
|
-70.33
|
-84.79
|
Operating Margin
|
-182.35%
|
-626.88%
|
-650.17%
|
61.5%
|
-872.86%
|
-455.89%
|
-376.91%
|
-476.63%
|
Earnings before Tax (EBT)
1 |
-36.8
|
-62.8
|
-63.78
|
117.8
|
-61.98
|
-65.7
|
-85.7
|
-96.3
|
Net income
1 |
-36.8
|
-62.8
|
-63.78
|
117.8
|
-61.98
|
-59.74
|
-61.79
|
-81.01
|
Net margin
|
-180.39%
|
-675.27%
|
-653.94%
|
62.13%
|
-885.49%
|
-430.92%
|
-331.1%
|
-455.34%
|
EPS
2 |
-1.720
|
-2.510
|
-2.060
|
3.540
|
-1.890
|
-1.696
|
-1.857
|
-2.202
|
Free Cash Flow
1 |
-2.22
|
-30.43
|
-91.89
|
117.4
|
-59.58
|
-67.2
|
-70.7
|
-85
|
FCF margin
|
-10.88%
|
-327.25%
|
-942.03%
|
61.91%
|
-851.14%
|
-484.75%
|
-378.87%
|
-477.79%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
98.66%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
99.65%
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-02-06
|
21-02-05
|
22-03-15
|
23-03-09
|
24-03-14
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
---|
Net sales
1 |
7.516
|
1.784
|
4.4
|
3.533
|
5.337
|
184.5
|
5.1
|
3.5
|
3.5
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-23.09
|
-35.2
|
-34.8
|
-12.84
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-307.24%
|
-1,973.09%
|
-790.91%
|
-363.35%
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-12.31
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-24.75
|
-38.1
|
-33.6
|
-12.31
|
-30.22
|
148.6
|
-30.8
|
-30.8
|
-31.22
|
Net margin
|
-329.27%
|
-2,135.65%
|
-763.64%
|
-348.4%
|
-566.2%
|
80.54%
|
-604.02%
|
-880%
|
-891.97%
|
EPS
2 |
-1.140
|
-1.370
|
-1.130
|
-0.3800
|
-0.9300
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-08-26
|
21-02-05
|
21-08-26
|
21-10-28
|
22-03-15
|
22-08-25
|
23-03-09
|
23-08-24
|
24-03-14
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
93.8
|
174
|
133
|
249
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-2.22
|
-30.4
|
-91.9
|
117
|
-59.6
|
-67.2
|
-70.7
|
-85
|
ROE (net income / shareholders' equity)
|
-49.8%
|
-77.9%
|
-59.5%
|
68.8%
|
-30.1%
|
-35.3%
|
-46%
|
-129%
|
ROA (Net income/ Total Assets)
|
-27.9%
|
-42.9%
|
-35.4%
|
54.2%
|
-26.9%
|
-31.4%
|
-39.7%
|
-97.9%
|
Assets
1 |
131.9
|
146.2
|
180.1
|
217.4
|
230.3
|
190.4
|
155.5
|
82.76
|
Book Value Per Share
2 |
2.510
|
3.680
|
3.340
|
7.230
|
-
|
3.430
|
2.180
|
0.5400
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
1.03
|
1.45
|
0.93
|
1.18
|
0.81
|
5
|
5
|
5
|
Capex / Sales
|
5.05%
|
15.6%
|
9.57%
|
0.62%
|
11.54%
|
36.07%
|
26.79%
|
28.11%
|
Announcement Date
|
20-02-06
|
21-02-05
|
22-03-15
|
23-03-09
|
24-03-14
|
-
|
-
|
-
|
Last Close Price
3.36
CHF Average target price
9.35
CHF Spread / Average Target +178.27% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.33% | 121M | | -2.31% | 103B | | +0.56% | 95.28B | | +1.69% | 22.15B | | -17.37% | 21.02B | | -9.30% | 18.15B | | -41.01% | 16.74B | | -14.85% | 16.05B | | +3.21% | 13.68B | | +33.54% | 12.17B |
Bio Therapeutic Drugs
|